Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
441
-
442
-
443
-
444
-
445
-
446
-
447
Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>.
Published 2015“…Cells receiving combination therapy had a significant decrease in proliferation compared to cells treated with LG only at 24, 48, and 72 hours, and compared to βHB only at 48, 72, and 96 hours, and exhibited a non-significant trend of decreased proliferation compared to LG + HBOT treated cells for the duration of the growth curve. …”
-
448
Decreased self-renewal capacity associated with senescence was prevented in human MSCs following treatment with Ki16425, an LPA<sub>1</sub>/LPA<sub>3</sub> antagonist.
Published 2012“…Human MSCs at passage 2 were cultured in the presence or absence of Ki16425 for the indicated days prior to cell lysis. Fold-change represents decrease in band intensity of Ki16425 treatment for 18 days compared with a control treatment for the same period of time. …”
-
449
Differentially regulated genes in cells with increased or decreased expression of miR-106a-5p.
Published 2013“…U251 cells were seeded into 6-well plates and transfected the following day using Lipofectamine 2000. For each well, 100 pmol of pre-ncRNA, pre-miR-106a-5p, anti-ncRNA or anti-miR-106a-5p was transfected. …”
-
450
-
451
-
452
Exploration of the connected interface (S100A1/p53 (1–73)) section in S100A1.
Published 2020Subjects: -
453
-
454
-
455
-
456
-
457
Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension.
Published 2012“…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”
-
458
-
459
-
460
Decrease in extracellular Zn<sup>2+</sup> in the hippocampus by zinc chelators.
Published 2013“…The data (mean ± SEM) represent the rate of ZnAF-2 intensity after zinc chelator injection to that after vehicle injection, which was expressed as 100% (right side).…”